multiple sclerosis news
Your Search Returned 500 tagged news reports
UCI stem-cell grant for M.S.: $4.8 million
40 pm · Thomas Lane, a UC Irvine neuroimmunologist who will receive a $4.8 million to investigate a treatment for multiple sclerosis using stem cells...A UC Irvine researcher will receive $4.8 million to develop a potential treatment for multiple
Tags: stem cells, cells treatment, Thomas Lane, multiple sclerosis, UCI, cord injury, UC Irvine, Switzerland, Zurich, Health Medical Pharma
Health Canada approves Biogen Tysabri label change
The product monograph change will help enable individual benefit risk assessment for MS patients. The new label identifies anti-JCV antibody status as a risk factor for developing an uncommon, but serious, brain infection known as progressive
Tags: Biogen Tysabri, jcv antibody, label change, Health Canada, United Kingdom, london, Neurological disorders, Immunosuppressants, Biogen Idec, multiple sclerosis
Vitamin D speeds up recovery in multiple sclerosis
Higher levels of vitamin D and sunlight exposure seem to lower relapse risk in multiple sclerosis (MS) sufferers, a study says. MS is a chronic degenerative and unpredictable condition that randomly attacks the brain and spinal cord. The symptoms of
Tags: multiple sclerosis, Pakistan, ISLAMABAD, Health Medical Pharma, Neurological disorders, Vitamin, Vitamin D, autoimmune diseases, Treatment of multiple sclerosis, Neurobiological brain disorder
Salon to hold benefit for MS society
A benefit for the Multiple Sclerosis Society is scheduled for Thursday at The Loft Hair Design & Skin Care...The event concludes eight weeks of fundraising, which included participation in the Legoland MS Walk, toward the salon's $5,000 goal. The
Tags: Escondido, multiple sclerosis, autoimmune diseases, Sclerosis
Your Warning Label Is My Sales Brochure
Gilenya was supposed to be the multiple sclerosis front runner, taking market share from treatments that have to be injected or infused because it's taken orally...The Food and Drug Administration slapped a more restrictive label on Gilenya after a
Tags: alexandria, pharmaceutical companies, Teva Pharmaceutical Industries, Health Medical Pharma, Neurological disorders, Glatiramer acetate, Biogen Idec, multiple sclerosis, pharmacology, autoimmune diseases
Win It! A Race to Erase MS Bracelet and T-Shirt
A Race to Erase MS Bracelet and T-Shirt May 15, 2012 The Orange You Happy to Erase MS campaign launches this month. Orange, the vibrant color of hope which has been chosen to represent Multiple Sclerosis, has inspired a variety of companies and
Tags: los angeles, multiple sclerosis, bracelets
UC Davis Clinical Trial of Smoked Cannabis for Spasticity in Multiple Sclerosis Patients Now Recruiting
The University of California Davis, in collaboration with the National Multiple Sclerosis Society, has permission to conduct a clinical trial of smoked cannabis on 60 M.S. patients. It's extremely rare to see something like this National Institutes
Tags: disease, bowel disease, inflammatory bowel, smoking cannabis, Berkeley, multiple sclerosis, autoimmune diseases, Medicinal plants, medical cannabis
Smoking pot may help relieve MS pain
Smoking marijuana may help relieve the muscle tightness and pain of multiple sclerosis, a small U.S. study suggests. Many people with MS often suffer from spasticity, an uncomfortable and disabling condition in which the muscles become tight and
Tags: multiple sclerosis, smoke marijuana, smoke pot, Canada, toronto, Medicinal plants, Cannabis, Spasticity, medical cannabis, Health Medical Pharma
U.S. FDA warns of injuries, deaths linked to 'liberation therapy' for multiple sclerosis
The FDA is warning health-care professionals and patients that injuries and death have been associated with the use of the experimental procedure. The therapy was devised by Italian physician Paolo Zamboni, who says MS is caused by vein blockages in
Tags: FDA, U.S, multiple sclerosis, Canada, Regina, Health Medical Pharma, angioplasty, cardiology, Food and Drug Administration, stroke
|| Aarkstore.com Latest Report || Autoimmune Disorders Therapeutics Market to 2017 - Launch
Aarkstore.com announces, The Latest market research report is available in its vast collection: Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and
Tags: therapeutics market, launch, Gilenya, Benlysta, drive, growth, multiple sclerosis, systemic lupus
Sitemap
Site Links
Site Topics
Contributions
- Report Your News
- User Leader Board
- Add your voice and contribute via your cellphone - check out how to Report News via Your Cellphone
- Blog Widget
- Widget for Blog Owner
- American Pundit